Chimerix EBITDA 2011-2024 | CMRX

Chimerix ebitda from 2011 to 2024. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.

Chimerix EBITDA 2011-2024 | CMRX

Chimerix ebitda from 2011 to 2024. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
Related Stocks
Company NameMarket
Cap
Amgen (AMGN)$173.4B
Vertex Pharmaceuticals (VRTX)$119.5B
Regeneron Pharmaceuticals (REGN)$114.9B
Gilead Sciences (GILD)$104.1B
Bristol Myers Squibb (BMY)$103.2B
CSL (CSLLY)$95.9B
GSK (GSK)$84.4B
Alnylam Pharmaceuticals (ALNY)$35.3B
Argenex SE (ARGX)$32.1B
Biogen (BIIB)$28.4B
BioNTech SE (BNTX)$28.1B
Moderna (MRNA)$25.3B
BeiGene (BGNE)$21.2B
Illumina (ILMN)$20.7B
Genmab (GMAB)$16.1B
BioMarin Pharmaceutical (BMRN)$13.4B
Incyte (INCY)$12.7B
Vaxcyte (PCVX)$12.6B
Bio-Techne Corp (TECH)$12.5B
Insmed (INSM)$12.5B
Exact Sciences (EXAS)$12.2B
Sarepta Therapeutics (SRPT)$11.9B
QIAGEN (QGEN)$10.3B
Bio-Rad Laboratories (BIO.B)$9.1B
Legend Biotech (LEGN)$9B
Roivant Sciences (ROIV)$8.5B
Ascendis Pharma (ASND)$8.4B
Repligen (RGEN)$8.2B
Intra-Cellular Therapies (ITCI)$7.7B
Exelixis (EXEL)$7.4B